Long-term response of over ten years with sorafenib monotherapy in metastatic renal cell carcinoma: a case report

BACKGROUND: Molecular targeted therapies have dramatically improved the prognosis of metastatic renal cell carcinoma. However, patients in whom the treatment could initially be effective will experience disease progression later. CASE PRESENTATION: A 74-year-old Japanese man who was diagnosed with r...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueda, Kosuke, Suekane, Shigetaka, Ogasawara, Naoyuki, Chikui, Katsuaki, Suyama, Shunsuke, Nakiri, Makoto, Nishihara, Kiyoaki, Matsuo, Mitsunori, Igawa, Tsukasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911686/
https://www.ncbi.nlm.nih.gov/pubmed/27312478
http://dx.doi.org/10.1186/s13256-016-0961-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4911686/
https://www.ncbi.nlm.nih.gov/pubmed/27312478
http://dx.doi.org/10.1186/s13256-016-0961-0

Ejemplares similares